RxDoctor Payments Data

Eric Troyer, MD

Family Medicine · Landis, NCNPI 1962409748

Payments from drug & device makers

$2,508in general payments, 2019–2025

Across 152 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$824
  • Indivior Inc.$484
  • Idorsia Pharmaceuticals US Inc$189
  • Braeburn Inc.$164
  • Orexo US, Inc.$128
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
  • plus $622 from 21 others

What the payments were for

  • Food & beverage$2,508100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,508 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,097
Medicare patients
37
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide60$41,941
OzempicSemaglutide22$35,339
BrixadiBuprenorphine23$33,064
FarxigaDapagliflozin Propanediol49$30,140
EliquisApixaban45$29,184
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl230$15,776
SuboxoneBuprenorphine Hcl/Naloxone Hcl50$15,530
QuliptaAtogepant12$13,186
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen321$11,258
SymbicortBudesonide/Formoterol Fumarate29$8,599
QuviviqDaridorexant Hcl17$8,344
Omeprazole199$3,523
Xtampza ErOxycodone Myristate12$3,358
Etodolac62$3,150
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen99$2,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Qulipta$824$55,12672 claims
AstraZenecaFarxiga, Symbicort$57$38,73978 claims
Novo NordiskOzempic$33$35,33922 claims
Braeburn Inc.Brixadi$164$33,06423 claims
PfizerEliquis$13$29,18445 claims
Indivior Inc.Suboxone$484$15,53050 claims
Idorsia Pharmaceuticals US IncQuviviq$189$8,34417 claims
Collegium Pharmaceutical, Inc.Xtampza Er$35$3,35812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Landis

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →